Lymphangioma is a rare, noncancerous fluid-filled growth that develops in the lymphatic system, most commonly appearing in newborns and young children. Understanding treatment approaches—from careful monitoring to advanced surgical techniques and emerging therapies—can help families navigate this condition with confidence and hope.

How Medical Care Approaches Lymphatic Malformations

When a child is diagnosed with a lymphangioma, or lymphatic malformation as doctors now prefer to call it, families naturally wonder what comes next. The good news is that many of these fluid-filled growths don’t require immediate treatment. The approach depends heavily on where the malformation is located, how large it has grown, and whether it’s causing any problems for the child. A small bump on the arm that doesn’t bother the child may simply need regular check-ups to make sure it isn’t growing or causing complications. On the other hand, a larger mass in the neck that makes breathing difficult requires prompt attention and intervention.^[1]

The main goals of treatment are to manage symptoms, prevent complications like infection or bleeding, and address any functional or cosmetic concerns. Doctors consider each child’s unique situation before recommending a treatment plan. Some lymphangiomas remain stable throughout life, while others grow slowly as the child grows. The decision to treat is never taken lightly, as each intervention carries its own benefits and risks.^[3]

Current medical guidelines recognize that lymphangiomas represent a spectrum of conditions rather than a single disease. Medical societies have moved away from older terms like “lymphangioma” toward “lymphatic malformation” to better reflect the developmental nature of these growths. This shift in understanding has also influenced how doctors approach treatment, focusing on personalized care rather than one-size-fits-all solutions.^[6]

Traditional Treatment Methods in Medical Practice

For many decades, the cornerstone of treating lymphangiomas has been careful observation combined with management of complications as they arise. This approach, often called “watchful waiting,” is particularly appropriate for small, asymptomatic malformations that don’t interfere with the child’s daily life or development. During this monitoring period, doctors track the growth through regular physical examinations and may use imaging tests like magnetic resonance imaging (MRI) or ultrasound to assess any changes in size or structure over time.^[1]

When lymphangiomas become infected, which is one of the most common complications, doctors prescribe antibiotics to fight the bacterial infection. The type of antibiotic chosen depends on the suspected bacteria causing the infection. Cellulitis, which is an infection of the skin and deeper tissues, can occur when the delicate vessels in a lymphangioma allow bacteria to enter and multiply. This infection causes redness, warmth, swelling, and tenderness in the affected area. Some children with lymphangioma circumscriptum, the superficial type with small bubble-like vesicles on the skin, experience recurrent episodes of cellulitis that require repeated courses of antibiotics over the years.^[10]

Pain management is another important aspect of standard care. While lymphangiomas typically don’t cause pain, complications such as sudden bleeding into the malformation or rapid expansion during infection can be uncomfortable. Over-the-counter pain relievers may be recommended for mild discomfort, while stronger medications might be prescribed for more significant pain episodes. Parents are taught to recognize warning signs that require immediate medical attention, such as sudden increase in size, severe pain, or breathing difficulties.^[3]

Historically, doctors have found that lymphangiomas don’t respond to certain treatments that work for other conditions. Radiation therapy, which uses high-energy rays to shrink tumors, has proven ineffective against lymphangiomas and is no longer recommended. Similarly, corticosteroids, powerful anti-inflammatory medications that help with some vascular conditions, don’t provide significant benefit for lymphatic malformations. This lack of response to medical therapy has pushed the field toward more invasive interventions when treatment becomes necessary.^[10]

Surgical Approaches to Lymphatic Malformations

Surgery remains one of the most definitive treatments for lymphangiomas, particularly when the malformation is small, well-defined, and located in an area where complete removal is possible without damaging surrounding structures. The surgical approach involves carefully cutting away the abnormal lymphatic tissue while preserving nearby blood vessels, nerves, and organs. For superficial lymphangiomas that lie just beneath the skin surface, this procedure can often achieve excellent results with relatively low risk of complications.^[11]

However, surgical excision is not without challenges. Lymphangiomas frequently extend deeper into tissues than they appear on the surface, with fingerlike projections spreading into surrounding structures like muscle, bone, or vital organs. Even when surgeons believe they have removed all visible abnormal tissue, microscopic extensions may remain, leading to regrowth of the malformation. Studies have shown recurrence rates ranging from 17 percent to as high as 100 percent, depending on the type and location of the lymphangioma and how completely it could be removed.^[13]

The decision to proceed with surgery involves weighing multiple factors. For a child with a large lymphangioma in the neck that affects breathing or swallowing, surgery may be necessary despite the risks. The procedure might need to be performed in stages, removing as much tissue as safely possible during each operation while monitoring the child’s recovery between procedures. Surgeons must balance the goal of complete removal against the risk of damaging important structures like the facial nerve, which controls facial expressions, or blood vessels that supply the brain.^[7]

Recovery from lymphangioma surgery varies depending on the extent of the procedure. Small, superficial removals may require only a few days of healing, while extensive operations in sensitive areas like the neck or mouth may necessitate weeks of careful monitoring. Some children need temporary feeding tubes if surgery affected their ability to swallow. Others may require specialized rehabilitation to regain normal function in affected areas. Parents should discuss expected recovery times and potential complications thoroughly with their surgical team before proceeding.^[9]

Sclerotherapy as a Minimally Invasive Option

In recent decades, sclerotherapy has emerged as an important alternative or complement to surgery for treating lymphangiomas. This technique involves injecting a special chemical solution directly into the abnormal lymphatic vessels. The solution irritates the vessel walls, causing them to stick together and eventually shrink. This approach is particularly valuable for large, deep lymphangiomas that would be difficult or dangerous to remove surgically, and for malformations that extend into multiple tissue layers.^[11]

Several different sclerosing agents have been used for lymphangiomas over the years. Doxycycline, an antibiotic medication, has sclerosing properties that make lymphatic vessels collapse and scar. Bleomycin, a chemotherapy drug, has been adapted for use in sclerotherapy, particularly for lymphangiomas in the head and neck region. OK-432, also known as Picibanil, is a preparation made from killed bacteria that triggers an inflammatory response leading to vessel closure. More recently, doctors have experimented with hypertonic saline solutions, which are simply very concentrated salt water that draws fluid out of tissues and causes vessels to shrink.^[10]

The choice of sclerosing agent often depends on the type of lymphangioma being treated. Macrocystic malformations, which contain large fluid-filled spaces bigger than two centimeters, tend to respond well to OK-432. One study found that intralesional OK-432 injection was particularly effective for these large-cyst types. On the other hand, microcystic lymphangiomas, composed of many tiny vessels and small cysts, are more challenging to treat with sclerotherapy and may require surgery or other approaches for best results.^[10]

Sodium tetradecyl sulfate represents another sclerosing option that has shown promise. This detergent-like substance damages the inner lining of lymphatic vessels, promoting their closure. When injected carefully into lymphangioma circumscriptum, the superficial type with skin vesicles, it can provide good outcomes. However, doctors must use this substance cautiously, as injection into surrounding tissues or blood vessels could cause unwanted side effects.^[13]

The sclerotherapy procedure typically requires sedation or general anesthesia, especially in young children who cannot remain still during the injection. Using ultrasound or other imaging guidance, the doctor inserts a thin needle into the lymphangioma and slowly injects the sclerosing solution. The amount injected and number of treatment sessions needed vary based on the size and type of malformation. Some children experience significant shrinkage after a single treatment, while others require multiple sessions spaced weeks or months apart to achieve optimal results.^[7]

Side effects from sclerotherapy are generally manageable but should be discussed before treatment. Swelling and pain at the injection site are common in the first few days following the procedure. Some children develop fever or flu-like symptoms as their body reacts to the sclerosing agent. More serious complications, though rare, can include damage to nearby nerves or blood vessels, skin breakdown over the treated area, or allergic reactions to the injected substance. Close monitoring after treatment helps catch and manage any problems early.^[13]

Laser and Energy-Based Treatments

For superficial lymphangiomas, particularly those appearing as clusters of small vesicles on the skin surface, laser therapy offers a less invasive treatment option. The carbon dioxide laser works by vaporizing the abnormal tissue layer by layer. This technique can remove the visible surface vessels while sealing the underlying channels that supply them. When performed skillfully, carbon dioxide laser treatment can significantly improve the appearance of lymphangioma circumscriptum and reduce symptoms like fluid leakage from the vesicles.^[13]

However, the effectiveness of laser therapy has important limitations. The laser energy can only penetrate to a certain depth in the skin. If the lymphangioma extends deeper into the dermis or subcutaneous tissue than the laser can reach, the malformation will likely regrow after treatment. This is a common problem because many lymphangiomas that appear superficial actually have deep components that aren’t visible on the skin surface. Patients may experience temporary improvement, only to see new vesicles appear months or years later as the deeper abnormal vessels continue to produce lymph fluid.^[13]

The pulsed dye laser represents another technology that has been tried for lymphangiomas. This laser specifically targets blood within vessels by heating the hemoglobin in red blood cells. While effective for conditions like port-wine stains that contain blood, its usefulness for lymphangiomas is more limited. Lymphatic vessels primarily contain clear or pale yellow lymph fluid rather than blood, meaning there’s less target chromophore for the laser to work on. Some lymphangiomas do contain blood from internal bleeding, and in these cases, pulsed dye laser may provide some benefit, but results are often disappointing.^[13]

Other energy-based treatments include radiofrequency therapy and electrodesiccation. Radiofrequency ablation uses electrical energy to heat and destroy abnormal tissue. Electrodesiccation employs high-frequency electrical current to dehydrate and destroy superficial lesions. These techniques may be useful for small, localized lymphangiomas, particularly the acquired type that develops later in life due to damage to normal lymphatic drainage. Treatment typically requires multiple sessions, and, like other therapies, doesn’t always prevent recurrence.^[10]

Cryotherapy, which uses extreme cold to freeze and destroy tissue, has also been employed for lymphangioma circumscriptum. During this procedure, liquid nitrogen or another freezing agent is applied to the skin vesicles, causing immediate tissue damage. Over subsequent days, the frozen area forms a blister and eventually heals, ideally with fewer or smaller vesicles remaining. While cryotherapy is relatively simple and inexpensive, it can cause scarring and pigment changes in the skin, and like other superficial treatments, often doesn’t address deeper components of the malformation.^[13]

Emerging Medical Therapies Under Investigation

The discovery that many lymphangiomas are caused by genetic mutations in the PIK3CA gene has opened new possibilities for targeted medical treatment. This gene provides instructions for making a protein involved in cell growth and division. When mutations make this protein overactive, it can lead to abnormal growth of lymphatic vessels. This breakthrough understanding, which affects approximately 75 to 80 percent of lymphatic malformations, has led researchers to explore medications that specifically target this pathway.^[6]

One medication showing promise in clinical trials is propranolol, a drug traditionally used to treat high blood pressure and heart conditions. While propranolol’s exact mechanism in treating lymphangiomas isn’t fully understood, it appears to affect the signals that promote growth of abnormal vessels. Some medical centers have begun using propranolol off-label for patients with difficult-to-treat lymphangiomas, particularly those with widespread disease. Early reports suggest it may help reduce pain and slow the growth of malformations, though more research is needed to establish optimal dosing and determine which patients benefit most.^[10]

Immunosuppressant medications represent another area of active investigation. These drugs work by dampening the immune system’s activity, which may reduce inflammation and slow the growth of abnormal lymphatic vessels. Boston Children’s Hospital and other specialized centers have reported using immunosuppressive therapy to help control pain and progression in patients with complex lymphatic malformations. The medications must be used carefully due to their side effects, which include increased risk of infections, but they offer hope for patients who haven’t responded to other treatments.^[7]

Recent advances in understanding the molecular biology of lymphatic malformations have led to consideration of targeted molecular therapies similar to those used in cancer treatment. Since approximately 75 to 80 percent of lymphatic malformations involve PIK3CA mutations, drugs that inhibit this specific protein pathway are being explored. These PIK3CA inhibitors could potentially shrink malformations by directly addressing their underlying cause at the molecular level. While still largely experimental, this approach represents a fundamentally different strategy from cutting, burning, or chemically destroying abnormal tissue.^[6]

Research into these emerging therapies is ongoing at major medical centers around the world. Clinical trials are evaluating safety, optimal dosing, and effectiveness of various targeted medications. Patients interested in accessing these experimental treatments may be able to participate in clinical trials if they meet eligibility criteria. Families should discuss with their healthcare team whether their child might be a candidate for any ongoing studies. It’s important to remember that experimental treatments haven’t been proven effective and may carry unknown risks, but they offer possibilities for patients with severe or treatment-resistant lymphangiomas.^[7]

Managing Complications and Long-Term Care

Even with treatment, lymphangiomas require ongoing management of potential complications. Infection remains one of the most common problems, particularly for lymphangioma circumscriptum where the superficial vesicles can rupture, creating openings for bacteria to enter. When vesicles break or are injured, they release lymph fluid and may bleed. Keeping the affected area clean and dry helps prevent infection, but some patients experience repeated episodes of cellulitis that require prompt antibiotic therapy. Severe or recurrent infections may occasionally necessitate hospitalization for intravenous antibiotics.^[10]

Bleeding represents another significant complication. The walls of lymphatic malformations contain fragile, malformed blood vessels that can rupture with minimal trauma or sometimes spontaneously. When this happens, blood fills the lymphatic spaces, causing sudden swelling, pain, and bruising. The affected area may become hard and tender. Most bleeding episodes resolve on their own with rest and cold compresses, but occasionally intervention is needed to stop persistent bleeding or drain large collections of blood that are causing pressure on nearby structures.^[3]

Children with lymphangiomas in certain locations require specialized monitoring. Those with malformations in the mouth or throat need regular assessment of their ability to eat, speak, and breathe normally. Involvement of the tongue can cause it to grow too large for the mouth, a condition called macroglossia, which interferes with feeding in infants and speech development in older children. Lymphangiomas near bones may cause abnormal bone growth or bone loss, requiring orthopedic consultation. Eye involvement can lead to vision problems that need ophthalmologic care.^[1]

Long-term follow-up is essential even after successful treatment. Lymphangiomas can recur years after apparently complete removal, and new areas of involvement can develop. Regular check-ups allow doctors to detect problems early, when they’re easier to manage. Imaging studies like MRI may be performed periodically to monitor for recurrence or progression. Families should maintain ongoing relationships with their healthcare team and promptly report any concerning changes such as new swelling, pain, or functional problems.^[10]

Most common treatment methods

• Observation and monitoring
  • Regular physical examinations to track growth and changes
  • MRI or ultrasound imaging to assess size and extent of malformation
  • Appropriate for small, asymptomatic lymphangiomas that don’t interfere with function
• Antibiotic therapy
  • Treatment of bacterial infections such as cellulitis
  • May require repeated courses for patients with recurrent infections
  • Sometimes necessitates intravenous administration for severe cases
• Surgical excision
  • Complete removal of abnormal lymphatic tissue when feasible
  • Most effective for small, well-defined, superficial malformations
  • May require staged procedures for large or complex lesions
  • Recurrence rates range from 17 to over 50 percent depending on completeness of removal
• Sclerotherapy
  • Injection of chemicals like doxycycline, bleomycin, or OK-432 into the malformation
  • Particularly effective for macrocystic types with large fluid-filled spaces
  • Sodium tetradecyl sulfate used for superficial lymphangioma circumscriptum
  • Hypertonic saline solutions offer another sclerosing option
  • May require multiple treatment sessions for optimal results
• Laser therapy
  • Carbon dioxide laser vaporization for superficial lesions
  • Pulsed dye laser for lesions with significant blood content
  • Limited penetration depth may result in recurrence from deeper components
• Other ablative techniques
  • Radiofrequency ablation using electrical energy to destroy tissue
  • Electrodesiccation for small, localized surface lesions
  • Cryotherapy using extreme cold to freeze abnormal tissue
• Emerging medical therapies
  • Propranolol for reducing pain and slowing growth in widespread disease
  • Immunosuppressant medications to control inflammation and progression
  • Targeted PIK3CA inhibitors addressing underlying genetic mutations
  • Mostly available through clinical trials or specialized centers

Supporting Your Child at Home

Families play a crucial role in managing lymphangiomas between medical visits. Protecting the affected area from injury is important, as trauma can trigger bleeding or infection. For children with superficial lymphangiomas, choosing appropriate clothing that doesn’t rub or irritate the vesicles helps prevent rupture. If vesicles do break open, keeping the area clean with gentle washing and applying an antibiotic ointment can reduce infection risk. Parents should contact their healthcare provider if signs of infection develop, such as increasing redness, warmth, swelling, pus, or fever.^[3]

Emotional support is equally important. Children with visible lymphangiomas may face questions or comments from peers about their appearance. Age-appropriate explanations can help children understand their condition and respond to curiosity from others. Some families find support groups helpful, whether in person or online, to connect with others facing similar challenges. Many children’s hospitals offer psychosocial support services to help families cope with the emotional aspects of living with a chronic medical condition.^[7]

Maintaining good general health supports optimal outcomes. A balanced diet, regular physical activity appropriate for the child’s condition, and adequate sleep all contribute to overall wellbeing and may help the body manage the malformation more effectively. While there are no specific dietary restrictions for lymphangioma, staying hydrated and maintaining a healthy weight are generally beneficial. Parents should discuss any concerns about activities or dietary choices with their healthcare team.^[3]

Outlook and Quality of Life

The prognosis for children with lymphangiomas varies considerably based on the specific characteristics of their malformation. Many small, localized lymphangiomas cause few problems throughout life, requiring minimal or no treatment. Others, particularly large macrocystic malformations in the head and neck region, may need multiple interventions over years. Despite the challenges, most children with lymphangiomas grow up to lead normal, healthy lives. Modern treatment approaches have significantly improved outcomes compared to decades past.^[3]

Quality of life depends not only on the malformation itself but also on how complications are managed and how families cope with the condition. Children who receive comprehensive care from experienced multidisciplinary teams, including surgeons, interventional radiologists, dermatologists, and other specialists as needed, tend to have better outcomes. Regular follow-up allows problems to be caught and addressed early, before they significantly impact daily life.^[7]

Ongoing research continues to improve understanding of lymphatic malformations and develop new treatment options. As scientists learn more about the genetic and molecular basis of these conditions, they’re identifying potential therapeutic targets that could lead to more effective, less invasive treatments in the future. Families affected by lymphangiomas can take hope from the rapid pace of discovery and the dedication of researchers and clinicians working to improve care.^[6]